OliX Pharmaceuticals,Inc (226950.KQ)

KRW 18430.0

(-6.07%)

Total Assets Summary of OliX Pharmaceuticals,Inc

OliX Pharmaceuticals,Inc's latest annual total assets in 2023 was 102.82 Billion KRW , down -22.48% from previous year.
OliX Pharmaceuticals,Inc's latest quarterly total assets in 2024 Q1 was 101.87 Billion KRW , down -0.93% from previous quarter.
OliX Pharmaceuticals,Inc reported annual total assets of 132.65 Billion KRW in 2022, up 53.05% from previous year.
OliX Pharmaceuticals,Inc reported annual total assets of 86.67 Billion KRW in 2021, up 10.3% from previous year.
OliX Pharmaceuticals,Inc reported quarterly total assets of 92.5 Billion KRW for 2024 Q2, down -9.2% from previous quarter.
OliX Pharmaceuticals,Inc reported quarterly total assets of 124.44 Billion KRW for 2023 Q1, down -6.19% from previous quarter.

Annual Total Assets Chart of OliX Pharmaceuticals,Inc (2023 - 2015)

Historical Annual Total Assets of OliX Pharmaceuticals,Inc (2023 - 2015)

Year	Total Assets	Total Assets Growth
2023	102.82 Billion KRW	-22.48%
2022	132.65 Billion KRW	53.05%
2021	86.67 Billion KRW	10.3%
2020	78.57 Billion KRW	73.82%
2019	45.2 Billion KRW	-18.75%
2018	55.63 Billion KRW	157.1%
2017	21.64 Billion KRW	42.85%
2016	15.14 Billion KRW	78.83%
2015	8.47 Billion KRW	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	101.87 Billion KRW	-0.93%
2024 Q2	92.5 Billion KRW	-9.2%
2023 Q1	124.44 Billion KRW	-6.19%
2023 FY	102.82 Billion KRW	-22.48%
2023 Q3	101.88 Billion KRW	-6.01%
2023 Q2	108.4 Billion KRW	-12.89%
2023 Q4	102.82 Billion KRW	0.92%
2022 Q2	130.17 Billion KRW	64.15%
2022 FY	132.65 Billion KRW	53.05%
2022 Q4	132.65 Billion KRW	5.42%
2022 Q3	125.83 Billion KRW	-3.33%
2022 Q1	79.3 Billion KRW	-8.5%
2021 Q4	86.67 Billion KRW	29.8%
2021 Q1	75.11 Billion KRW	-4.41%
2021 Q2	74.01 Billion KRW	-1.45%
2021 Q3	66.77 Billion KRW	-9.79%
2021 FY	86.67 Billion KRW	10.3%
2020 Q4	78.57 Billion KRW	131.58%
2020 FY	78.57 Billion KRW	73.82%
2020 Q1	41.23 Billion KRW	-8.79%
2020 Q2	37.27 Billion KRW	-9.61%
2020 Q3	33.93 Billion KRW	-8.97%
2019 Q4	45.2 Billion KRW	-9.17%
2019 FY	45.2 Billion KRW	-18.75%
2019 Q3	49.77 Billion KRW	-7.15%
2019 Q2	53.6 Billion KRW	-4.38%
2019 Q1	56.06 Billion KRW	0.76%
2018 Q1	- KRW	0.0%
2018 Q4	55.63 Billion KRW	0.0%
2018 FY	55.63 Billion KRW	157.1%
2017 FY	21.64 Billion KRW	42.85%
2016 FY	15.14 Billion KRW	78.83%
2015 FY	8.47 Billion KRW	0.0%

Peer Total Assets Comparison of OliX Pharmaceuticals,Inc

Name	Total Assets	Total Assets Difference
HLB Co., Ltd.	751.72 Billion KRW	86.321%
iNtRON Biotechnology, Inc.	98.61 Billion KRW	-4.27%
BINEX Co., Ltd.	257.01 Billion KRW	59.992%
Bioneer Corporation	315.48 Billion KRW	67.408%
Anterogen.Co.,Ltd.	149.43 Billion KRW	31.189%
MEDIPOST Co., Ltd.	449.39 Billion KRW	77.119%
CrystalGenomics, Inc.	243.11 Billion USD	57.705%
Helixmith Co., Ltd	227.27 Billion KRW	54.758%
Chabiotech Co.,Ltd.	1725.57 Billion KRW	94.041%
Medy-Tox Inc.	611.62 Billion KRW	83.188%
Peptron, Inc.	52.49 Billion KRW	-95.872%
Amicogen, Inc.	467.09 Billion KRW	77.986%
Genexine, Inc.	376.58 Billion KRW	72.696%
HLB Therapeutics Co.,Ltd.	200.79 Billion KRW	48.791%
LegoChem Biosciences, Inc.	189.5 Billion KRW	45.739%
ALTEOGEN Inc.	256.09 Billion KRW	59.85%
PharmaResearch Co., Ltd.	535.28 Billion KRW	80.79%
SillaJen, Inc.	76.71 Billion KRW	-34.035%
JETEMA, Co., Ltd.	252.14 Billion KRW	59.22%
Genomictree Inc.	132.84 Billion KRW	22.597%
MedPacto, Inc.	80.47 Billion KRW	-27.774%
D&D Pharmatech	79.2 Billion KRW	-29.824%
EASY BIO,Inc.	172.04 Billion KRW	40.232%
GI Innovation, Inc.	81.34 Billion KRW	-26.414%